4.5 Article

Interleukin-10 promoter polymorphism as risk factor to develop invasive pulmonary aspergillosis

期刊

IMMUNOLOGY LETTERS
卷 109, 期 1, 页码 76-82

出版社

ELSEVIER SCIENCE BV
DOI: 10.1016/j.imlet.2007.01.005

关键词

IPA; galactomannan; IL-10 promoter polymorphism; susceptibility

向作者/读者索取更多资源

This present study was undertaken to examine the role of the host response to Aspergillus fumigatus in the development of clinical symptoms of invasive pulmonary aspergillosis (IPA). The natural outcome and response to IPA infection varies between individuals. Whereas some variation may be attributable to fungi and environmental variables, it is probable that host genetic background also plays a significant role. Interleukin (IL)-10 has a key function in the regulation of cellular immune responses and is involved in various inflammatory diseases. IL-10 promoter carries a polymorphism that has been associated to production levels. Our aim was to investigate the role of this polymorphism in susceptibility to develop IPA infection. The study included 120 haematological patients and 124 age and sex-matched controls and bi-allelic IL-10 - 1082(G/A) polymorphism was examined. Genotypic (p = 0.385) and allelic frequencies (p = 0.527, OR = 0.89, 95% CI = 0.78-1.60) were similar between patients and healthy controls. IPA was diagnosed in 59 of the 120 patients according to consensus criteria published by the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group (EORTC/IFICG). Our results provide evidence that IL-10 - 1082(AA) genotype is associated with resistance to develop IPA) = 0.001). Allele frequency of IL-10 - 1082A allele was weakly associated with susceptibility to develop IPA infection (p = 0.052). In conclusion, these results suggest that differential production of IL-10 may alter the risk for IPA in haematological patients. (c) 2007 Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据